Evolent Health (EVH) Asset Writedowns and Impairment (2023 - 2024)
Evolent Health's quarterly Asset Writedowns and Impairment came in at $2.6 million in Q4 2024, down 89.25% quarter-over-quarter from $24.1 million in Q2 2023.
Evolent Health has reported Asset Writedowns and Impairment for 2 years, with the latest figure at $2.6 million in Q4 2024.
- For the quarter ending Q4 2024, Asset Writedowns and Impairment changed N/A year-over-year to $2.6 million; the trailing twelve-month figure through Dec 2024 stood at $2.6 million (down 89.25% YoY), and the FY2024 full-year result was $2.6 million, down 89.25% from the prior year.
- Asset Writedowns and Impairment for Q4 2024 stood at $2.6 million, down from $24.1 million in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $24.1 million in Q2 2023, with the low at $2.6 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | Evolent Health | 467.76 Mn | 301.79 Mn | 83.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 2.59 Mn |
| Dec 31, 2024 | 2.59 Mn |
| Jun 30, 2023 | 24.07 Mn |
| Jun 30, 2023 | 24.07 Mn |